Matthew is a health economist with a PhD in health sciences studying the use of health technology assessment (HTA) in reimbursement decision-making with over 14 years’ (>150 MA/HEOR projects) consulting experience. At Evidera, Matthew provides senior leadership for large projects on HTA strategy, integrated scientific advice, and HTA policy for pharmaceutical, vaccine, and medical device companies across several disease areas. His experience is wide-ranging, from projects for HTA scientific advice, parallel regulatory and HTA scientific advice, joint regulatory and HTA scientific advice, multiple HTA scientific advice, value proposition development, HTA policy, HTA landscaping, HTA evidence generation gap analysis, evidence synthesis, health economic modeling, and payer advisory boards. Matthew has held more than 10 integrated scientific advice roundtable events, presented at international conferences, and published over 35 reports/papers on HTA and HEOR topics. He was a co-author of a study that won the Egon Jonsson award in 2009/2010 for the most outstanding manuscript published in the International Journal of Technology Assessment in Health Care on the harmonization of HTA internationally.
Prior to joining Evidera, Matthew developed the early integrated HTA scientific practice at ICON and led the Mapi Group HTA, Strategy, and Communication team with experience of more than 40 formal integrated HTA scientific advice engagements across a range of disease areas. He was a senior consultant at the York Health Economics Consortium at the University of York leading projects for the National Institute for Health and Care Excellence, Department of Health, Patient Safety and Research Portfolio, and General Medical Council.
Matthew has a PhD in health sciences from the University of York, an MSc in economics, and a BSc honours in economics from the University of Warwick.